PT97913A - Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem - Google Patents
Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem Download PDFInfo
- Publication number
- PT97913A PT97913A PT97913A PT9791391A PT97913A PT 97913 A PT97913 A PT 97913A PT 97913 A PT97913 A PT 97913A PT 9791391 A PT9791391 A PT 9791391A PT 97913 A PT97913 A PT 97913A
- Authority
- PT
- Portugal
- Prior art keywords
- compound
- pyridyl
- aliphatic
- methoxyphenyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53439790A | 1990-06-07 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT97913A true PT97913A (pt) | 1992-03-31 |
Family
ID=24129867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97913A PT97913A (pt) | 1990-06-07 | 1991-06-07 | Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0593464A1 (enExample) |
| JP (1) | JPH07116150B2 (enExample) |
| KR (1) | KR930700102A (enExample) |
| CN (1) | CN1058015A (enExample) |
| AU (1) | AU655428B2 (enExample) |
| CA (1) | CA2083957A1 (enExample) |
| FI (1) | FI925545L (enExample) |
| HU (1) | HUT64747A (enExample) |
| IL (1) | IL98387A0 (enExample) |
| MA (1) | MA22195A1 (enExample) |
| MX (1) | MX26167A (enExample) |
| NZ (1) | NZ238426A (enExample) |
| PL (1) | PL290587A1 (enExample) |
| PT (1) | PT97913A (enExample) |
| TW (1) | TW221809B (enExample) |
| WO (1) | WO1991018601A1 (enExample) |
| ZA (1) | ZA914322B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06510786A (ja) * | 1991-09-19 | 1994-12-01 | スミスクライン・ビーチャム・コーポレイション | ロイコトリエン関連疾患治療用ピリジン化合物 |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| EP0649408A4 (en) * | 1992-06-30 | 1995-06-21 | Smithkline Beecham Corp | METHOD FOR THE PRODUCTION OF PHENYLTHIOMETHYLPYRIDINYLALKENOATS. |
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| GR1001409B (el) * | 1992-10-15 | 1993-11-30 | Smithkline Beecham Corp | Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια. |
| ES2065234B1 (es) * | 1992-10-27 | 1995-09-01 | Smithkline Beecham Corp | Compuestos para tratar enfermedades relacionadas con los leucotrienos. |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| EP0942903A1 (en) * | 1996-09-26 | 1999-09-22 | Novartis AG | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| EP1660094A4 (en) | 2003-08-26 | 2009-09-16 | Univ Colorado | INHIBITORS OF SERINE PROTEASE ACTIVITY AND USES THEREOF IN METHODS AND PREPARATIONS FOR TREATING BACTERIAL INFECTIONS |
| EP3812363B1 (en) * | 2018-06-22 | 2022-08-03 | Panasonic Holdings Corporation | Organic salt, hydroxy-radical sensor including same, and detection medium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
-
1991
- 1991-05-31 AU AU81896/91A patent/AU655428B2/en not_active Ceased
- 1991-05-31 CA CA002083957A patent/CA2083957A1/en not_active Abandoned
- 1991-05-31 WO PCT/US1991/003772 patent/WO1991018601A1/en not_active Ceased
- 1991-05-31 HU HU9203867A patent/HUT64747A/hu unknown
- 1991-05-31 JP JP3511468A patent/JPH07116150B2/ja not_active Expired - Lifetime
- 1991-05-31 FI FI925545A patent/FI925545L/fi not_active Application Discontinuation
- 1991-05-31 EP EP91911699A patent/EP0593464A1/en not_active Ceased
- 1991-05-31 KR KR1019920703091A patent/KR930700102A/ko not_active Abandoned
- 1991-06-03 MA MA22441A patent/MA22195A1/fr unknown
- 1991-06-05 IL IL98387A patent/IL98387A0/xx unknown
- 1991-06-06 ZA ZA914322A patent/ZA914322B/xx unknown
- 1991-06-06 NZ NZ238426A patent/NZ238426A/en unknown
- 1991-06-06 TW TW080104434A patent/TW221809B/zh active
- 1991-06-07 PT PT97913A patent/PT97913A/pt not_active Application Discontinuation
- 1991-06-07 MX MX2616791A patent/MX26167A/es unknown
- 1991-06-07 CN CN91104563A patent/CN1058015A/zh active Pending
- 1991-06-07 PL PL29058791A patent/PL290587A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU655428B2 (en) | 1994-12-22 |
| TW221809B (enExample) | 1994-03-21 |
| EP0593464A1 (en) | 1994-04-27 |
| HU9203867D0 (en) | 1993-03-29 |
| WO1991018601A1 (en) | 1991-12-12 |
| PL290587A1 (en) | 1992-08-24 |
| CA2083957A1 (en) | 1991-12-08 |
| CN1058015A (zh) | 1992-01-22 |
| MA22195A1 (fr) | 1992-04-01 |
| KR930700102A (ko) | 1993-03-13 |
| NZ238426A (en) | 1994-11-25 |
| FI925545A7 (fi) | 1992-12-07 |
| JPH07116150B2 (ja) | 1995-12-13 |
| FI925545A0 (fi) | 1992-12-07 |
| EP0593464A4 (en) | 1993-02-12 |
| MX26167A (es) | 1994-02-28 |
| FI925545L (fi) | 1992-12-07 |
| ZA914322B (en) | 1992-06-24 |
| IL98387A0 (en) | 1992-07-15 |
| JPH05507492A (ja) | 1993-10-28 |
| AU8189691A (en) | 1991-12-31 |
| HUT64747A (en) | 1994-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60215699T2 (de) | Quinolinone als prostaglandin rezeptor liganden | |
| US20030088103A1 (en) | PPARgamma modulators | |
| KR20010110669A (ko) | 프로테아제 억제제로서의 화합물 및 조성물 | |
| PT97913A (pt) | Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem | |
| AU7703300A (en) | Compounds and pharmaceutical compositions as cathepsin s inhibitors | |
| US5334596A (en) | Fibrinogen receptor antagonists | |
| DE60008399T2 (de) | Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden | |
| JPH07118237A (ja) | プロペン酸誘導体 | |
| AP333A (en) | Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases. | |
| KR100273181B1 (ko) | 신규 피리돈 유도체 그의 제조방법 그에 의해 얻어진 신규 중간체, 그의 의약으로서의 용도 및 그를 함유하는 제약 조성물 | |
| CN103003242A (zh) | 吡啶-2-基硫基酸酯及其制备方法 | |
| EP1103543A1 (en) | Novel urea derivatives bearing nitrogenous aromatic heterocycles | |
| JP3230682B2 (ja) | 医薬ピリジン化合物 | |
| JPH05507475A (ja) | ロイコトリエン関連疾患治療用安息香酸誘導体 | |
| PT97911A (pt) | Processo de preparacao de derivados de acidos piridilbenzoicos ligados a amida e de composicoes farmaceuticas | |
| EP0430459A1 (en) | Tetrahydronaphthalene derivatives and preparation thereof | |
| US5656636A (en) | Pyridine compounds for treating leukotriene-related diseases | |
| WO1993010780A1 (en) | Heterocyclic-substituted pyridine compounds and uses | |
| SI9200314A (sl) | Spojine za zdravuanje bolezni, ki so v zvezi z levkotrieni | |
| JP2000119249A (ja) | 含窒素芳香族複素環を有する新規ウレア誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19911115 |
|
| FC3A | Refusal |
Effective date: 19981117 |